⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Novumgen and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Novumgen
↗London, United Kingdom
Novumgen is a specialty pharmaceutical and biotechnology company focused on the development, manufacturing, and supply of innovative medicines. The company leverages expertise in regulatory affairs and drug development to expedite market entry, offering services such as product licensing, co-development, and technology transfer.
Headquartered in London, UK, with additional operations in India, Novumgen focuses on therapeutic areas including oncology, inflammation, immunology, anti-infectives, and rare diseases. The company aims to address unmet medical needs by transforming scientific discoveries into practical, high-quality healthcare solutions for patients worldwide.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Specialty Pharmaceuticals
SIZE & FINANCIALS
Employees:51-200
Revenue:$1M-$6M
Founded:2021
Ownership:private
Status:operating
FUNDING
Total Raised:$0M
PIPELINE
Stage:Discovery
Lead Drug Stage:Not publicly disclosed
Modalities:Small molecule, Biologicals
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Novumgen Private Limited (India)
Key Partnerships:Various academic institutions and industry partners for co-development and licensing
COMPETITION
Position:Emerging
Competitors:Aragen, OneSource, Kardigan
LEADERSHIP
Key Executives:
Kamlesh Patel - CEO and Founder
LINKS
Website:novumgen.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Novumgen. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.